Likewise, MARCKS etiology and potential as a treatment target should be explored in other neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Huntington’s disease, where dendritic spine loss has been observed to preclude neurodegeneration. This evidence concerns the gene MARCKS and amyotrophic lateral sclerosis.